 Use aminohydroxypropylidene bisphosphonate AHPrBP APD treatment hypercalcemia patients renal impairment Aminohydroxypropylidene bisphosphonate AHPrBP APD new bisphosphonate effective control hypercalcemia due variety causes Renal impairment use bisphosphonates pre-existing renal impairment contraindication use AHPrBP successful use intravenous AHPrBP hypercalcemia patients renal impairment dialysis-dependent significant side effects particular deterioration renal function Intravenous AHPrBP safe effective agent control hypercalcemia patients renal impairment